Illumina Inc. (NASDAQ: ILMN) is a large market cap stock with a market cap of 24586.89. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 59.84, a forward P/E of 41.84 and EPS of 2.78. At a stock price of 166.06 (-0.22%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 28.90%, more recently this last year it has grown by 30.50%. The next year growth is going to be about 17.97% and more long-term 16.45% after five years. EPS growth quarter over quarter is -34.30%. Sales growth for the past five years have been 19.70% and sales growth quarter over quarter is 6.20%.
For performance, Illumina Inc. the past week has seen a gain of 9.99%. For the last month performance for Illumina Inc. is 23.26%. While the last quarter is 22.59% and half year, 7.89%. Finally for the year, performance is -23.38%.
The 52-week high for Illumina Inc., is at -24.81%, and for the 52-week low it comes to a value of 30.65%. The 20-day simple moving average is 15.41% and 6.61% for the 200-day simple moving average.
Volatility for the week is at 4.29%, and for the month it is 3.00%. Illumina Inc., has a target price of 153.53.
In terms of debt, long term debt/equity is 0.51, and for total debt/equity Illumina Inc. has 0.51. The gross margin is 69.70%, while operating margin is 24.80%, the profit margin is 18.40%. The current ratio is 4.3 and the quick ratio is 3.7.
Insider ownership is at 1.20%, with instituitional ownership at 96.80%. Illumina Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 147.74. The shares float is 145.7, with the float short at 5.16%, with short ratio coming to 6.16.
In terms of returns, the return on assets see Illumina Inc., get 11.10%, with its returns on investment at 16.60%. Return on equity is 21.90%. So will the investors see the target price of 153.53, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.